Evidence for DNA methylation mediating genetic liability to non-syndromic cleft lip/palate

Epigenomics. 2019 Feb;11(2):133-145. doi: 10.2217/epi-2018-0091. Epub 2019 Jan 14.

Abstract

Aim: To determine if nonsyndromic cleft lip with or without cleft palate (nsCL/P) genetic risk variants influence liability to nsCL/P through gene regulation pathways, such as those involving DNA methylation.

Materials & methods: nsCL/P genetic summary data and methylation data from four studies were used in conjunction with Mendelian randomization and joint likelihood mapping to investigate potential mediation of nsCL/P genetic variants.

Results & conclusion: Evidence was found at VAX1 (10q25.3), LOC146880 (17q23.3) and NTN1 (17p13.1), that liability to nsCL/P and variation in DNA methylation might be driven by the same genetic variant, suggesting that genetic variation at these loci may increase liability to nsCL/P by influencing DNA methylation. Follow-up analyses using different tissues and gene expression data provided further insight into possible biological mechanisms.

Keywords: ALSPAC; epigenetics; mendelian randomization; nsCL/P.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Cleft Lip / genetics*
  • Cleft Lip / pathology
  • Cleft Palate / genetics*
  • Cleft Palate / pathology
  • DNA Methylation*
  • Epigenesis, Genetic
  • Female
  • Genetic Variation*
  • Homeodomain Proteins / genetics
  • Humans
  • Male
  • Mendelian Randomization Analysis
  • Netrin-1 / genetics
  • Transcription Factors / genetics

Substances

  • Homeodomain Proteins
  • NTN1 protein, human
  • Transcription Factors
  • VAX1 protein, human
  • Netrin-1